Trial Profile
A randomized controlled trial comparing PCAB and PPI therapy for Los Angeles classification Grade C/D reflux esophagitis patient
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2020
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Esomeprazole; Rabeprazole
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 13 Mar 2018 New trial record